Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Umeta-mimi Adjuvant Treatment for Bacterial Vaginosis
NCT04771728Phase 4Recruiting
- Sponsor
- Peking University Shenzhen Hospital
- Start
- Feb 2020
- Primary completion
- Dec 2026
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in bacterial vaginosis (BV) (2 arms), sponsored by Peking University Shenzhen Hospital. Primary endpoint: Cure rate of BV at 14 days. Started Feb 2020; status: recruiting.
02
Conditions
bacterial vaginosis (BV)
Beyond the preview
Go deeper on NCT04771728.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04771728.